ArcelorMittal said on Thursday that it would build an advanced steel manufacturing facility in Calvert, Alabama, as it seeks ...
Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...
Sales of the firm's bispecific T-cell engager Blincyto increased more than 50 percent from the fourth quarter of 2023 to 2024.
Amgen posted Q4 sales of $9.1 billion, up 11%, surpassing forecasts. EPS beat estimates, and analysts remain optimistic about growth prospects in 2025.
After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...
Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...
Amazon, Keeneland, the Pikeville Medical Center, AirBnB. Who else is spending big to lobby the Kentucky General Assembly?
2d
Hosted on MSNThe Dow Jones Industrials Are Winning 2025: 4 Highest-Yielding Dogs of the Dow Are StealsThe Dow Jones industrial average (DJIA) is a price-weighted average of 30 blue-chip U.S. stocks, often industry leaders. It ...
The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...
Plant-derived proteins are booming in cosmetics for their natural, effective, and eco-friendly benefits, driving UK market growth amid rising beauty trends. Ankush Nikam Future Market Insights, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results